Genus plc (LON:GNS)
London · Delayed Price · Currency is GBP · Price in GBX 3,060.00
+95.00 (3.20%)
At close: Feb 3, 2026
Genus Revenue
In the fiscal year ending June 30, 2025, Genus had annual revenue of 672.80M GBP with 0.60% growth. Genus had revenue of 336.40M in the half year ending June 30, 2025, a decrease of -0.91%.
Revenue
672.80M
Revenue Growth
+0.60%
P/S Ratio
2.95
Revenue / Employee
210.91K
Employees
3,190
Market Cap
1.98B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 672.80M | 4.00M | 0.60% |
| Jun 30, 2024 | 668.80M | -20.90M | -3.03% |
| Jun 30, 2023 | 689.70M | 96.30M | 16.23% |
| Jun 30, 2022 | 593.40M | 19.10M | 3.33% |
| Jun 30, 2021 | 574.30M | 22.90M | 4.15% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Oxford Nanopore Technologies | 204.69M |
| Oxford Biomedica | 151.21M |
| hVIVO | 54.47M |
| Bioventix | 13.12M |
| Scancell Holdings | 4.71M |
| PureTech Health | 4.66M |
| SkinBioTherapeutics | 4.64M |
| 4basebio | 1.78M |
Genus News
- 5 days ago - Genus Plc: A Uniquely Positioned, Under-Appreciated Animal Genetics Company - Seeking Alpha
- 8 days ago - Genius Group (GNS) Shares Vision for Future Education with AI-Driven Curriculum - GuruFocus
- 18 days ago - UK animal genetics firm Genus surges on annual profit forecast upgrade - Reuters
- 18 days ago - UK Stock Market News: Johnson Services, Genus, Gleeson - The Armchair Trader
- 22 days ago - Genius Group (GNS) Announces Share Count Date for Asset Purchase Agreement - GuruFocus
- 4 weeks ago - GNS Expands Educational Project in Bali with Genius City Initiative - GuruFocus
- 6 weeks ago - Genius Group (GNS) Pursues Dual Listing on Australian Securities Exchange - GuruFocus
- 7 weeks ago - GNS Executes Fourth Stock Buyback, Acquiring One Million Shares - GuruFocus